4 free views remaining today

Charcot-Marie-Tooth disease X-linked recessive 2

ICD-10 Codes

Related ICD-10:

Description

Charcot-Marie-Tooth disease, specifically the X-linked recessive type 2 (CMTX2), is a rare genetic peripheral sensorimotor neuropathy characterized by an infantile-to-childhood onset of progressive distal muscle weakness and atrophy. This condition primarily affects males, as it is inherited in an X-linked recessive pattern.

Key Features:

  • Inheritance Pattern: X-linked recessive, meaning the gene responsible for the condition is located on the X chromosome.
  • Age of Onset: Typically occurs in infancy or childhood.
  • Muscle Weakness and Atrophy: Progressive distal muscle weakness and atrophy, more prominent in the lower extremities than in the upper extremities.
  • Sensory Impairment: Some individuals may experience sensory impairment.

Prevalence: CMTX2 is a rare subtype of Charcot-Marie-Tooth disease, with limited information available on its prevalence. However, it is considered to be one of the less common forms of CMT.

References:

  • [4] A rare genetic peripheral sensorimotor neuropathy characterized by an X-linked recessive inheritance pattern and the infantile-to childhood-onset of progressive ...
  • [5] A rare genetic peripheral sensorimotor neuropathy with an X-linked recessive inheritance pattern and the infantile to childhood-onset of progressive, distal ...

Additional Characteristics

  • Inheritance Pattern: X-linked recessive
  • Age of Onset: Typically occurs in infancy or childhood
  • Muscle Weakness and Atrophy: Progressive distal muscle weakness and atrophy, more prominent in the lower extremities than in the upper extremities
  • Sensory Impairment: Some individuals may experience sensory impairment

Signs and Symptoms

Common Signs and Symptoms of Charcot-Marie-Tooth Disease Type X (X-linked Recessive)

Charcot-Marie-Tooth disease type X, also known as CMTX, is a genetic disorder that affects the peripheral nerves. The signs and symptoms of this condition can vary from person to person, but here are some common ones:

  • Weakness and atrophy of muscles in the lower legs: Individuals with CMTX often experience weakness and muscle wasting in their lower legs, which can start as early as childhood [2].
  • Hand weakness: As the disease progresses, people with CMTX may also experience hand weakness, which can make everyday activities more challenging [2].
  • Muscle weakness and atrophy: Muscle weakness and atrophy are common symptoms of CMTX, affecting both the upper and lower limbs [6, 12].
  • Sensory impairment: People with CMTX may experience sensory impairment, particularly in their lower extremities, which can lead to numbness or tingling sensations [6, 12].

These symptoms can start gradually in adolescence but can begin earlier or later. It's essential to note that the severity and progression of CMTX can vary significantly from person to person.

References:

[2] - Individuals experience weakness and atrophy of the muscles of the lower legs beginning in childhood; later they experience hand weakness, ...

[6] - Disease definition. A rare genetic, axonal, peripheral sensorimotor neuropathy, characterized by an X-linked recessive inheritance pattern and the neonatal- to early childhood-onset of severe, slowly progressive, distal muscle weakness and atrophy (in particular of the peroneal group), as well as sensory impairment (with the lower extremities being more affected than the upper extremities ...

[12] - It is inherited in an X-linked recessive manner.

Diagnostic Tests

Diagnostic Tests for Charcot-Marie-Tooth Disease (CMT) X-linked Recessive 2

Charcot-Marie-Tooth disease is a group of inherited motor and sensory peripheral neuropathies, and the diagnostic tests for CMT X-linked recessive 2 are crucial in confirming the diagnosis. Here are some of the diagnostic tests used to diagnose CMT X-linked recessive 2:

  • Genetic testing: Genetic testing is a reliable method for diagnosing CMT X-linked recessive 2. Pulsed field gel electrophoresis and specialized fluorescent in-situ hybridization (FISH) assay are the most reliable genetic tests available [8].
  • Nerve conduction studies: Nerve conduction studies, including electromyogram (EMG), can help diagnose CMT X-linked recessive 2. These tests measure the speed and strength of electrical signals traveling through nerves [9].
  • Spinal tap (lumbar puncture): A spinal tap may be performed to test cerebrospinal fluid for signs of nerve damage.
  • Magnetic resonance imaging (MRI): MRI can help identify nerve damage and other complications associated with CMT X-linked recessive 2.

Confirming the Diagnosis

A positive genetic test can confirm diagnosis in most people with CMT X-linked recessive 2. However, a negative result does not exclude the disease, as an unidentified gene may be missed [5].

References:

  • [8] Pulsed field gel electrophoresis and specialized fluorescent in-situ hybridization (FISH) assay are the most reliable genetic tests available for diagnosing CMT X-linked recessive 2.
  • [9] Nerve conduction studies, including electromyogram (EMG), can help diagnose CMT X-linked recessive 2.
  • [5] A positive genetic test can confirm diagnosis in most people with CMT X-linked recessive 2.

Treatment

Current Status of Drug Treatment for CMTX

Unfortunately, there is no specific drug treatment available for Charcot-Marie-Tooth disease (CMT) X-linked recessive (CMTX). The management and treatment options for CMTX primarily focus on symptom relief, rather than a cure.

  • Rehabilitation therapy: This includes physical therapy to improve muscle strength and mobility, as well as occupational therapy to enhance daily functioning.
  • Surgical treatment of skeletal deformities: In some cases, surgery may be necessary to correct skeletal deformities or other complications associated with CMTX.

It's worth noting that researchers are actively exploring various therapeutic approaches for CMT, including gene therapy. However, these efforts are still in the early stages, and more research is needed to develop effective treatments for this condition.

References:

  • [6] Current management of Charcot-Marie-Tooth disease X-linked (CMTX) primarily focuses on rehabilitation and occupational therapy with psychological support.
  • [5] Management and treatment. There is no drug treatment available. Rehabilitation therapy and surgical treatment of skeletal deformities are the only options.

Please note that these references are based on the search results provided, which may not be exhaustive or up-to-date. If you have any further questions or would like more information, feel free to ask!

Recommended Medications

  • No specific drug treatment available
  • Rehabilitation therapy
  • Surgical treatment of skeletal deformities

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

The differential diagnosis for Charcot-Marie-Tooth disease (CMT) X-linked recessive type includes other forms of CMT, as well as chronic inflammatory demyelinating polyneuropathy (CIDP), particularly for the subtype CMTX1.

  • Other forms of CMT: The differential diagnosis for CMTX includes other subtypes of Charcot-Marie-Tooth disease, such as autosomal dominant and autosomal recessive forms. These forms can present with similar clinical features, making it essential to consider them in the diagnostic process.
  • Chronic inflammatory demyelinating polyneuropathy (CIDP): CIDP is a condition that affects the nerves and can cause symptoms similar to CMTX. The differential diagnosis for CMTX1 specifically includes CIDP, as these two conditions can present with overlapping clinical features.

It's essential to consider these potential diagnoses when evaluating patients with suspected CMTX, as accurate diagnosis and differentiation from other neuropathies are crucial for guiding treatment decisions and providing appropriate care for affected individuals. [8][3]

Additional Differential Diagnoses

  • Chronic inflammatory demyelinating polyneuropathy (CIDP)
  • Other forms of CMT

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_4562
owl#annotatedSource
t365687
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#hasDbXref
ORDO:101076
oboInOwl#id
DOID:0110208
core#notation
DOID:0110208
IAO_0000115
A Charcot-Marie-Tooth disease X-linked that has_material_basis_in variation in the region Xp22.2.
rdf-schema#label
Charcot-Marie-Tooth disease X-linked recessive 2
oboInOwl#hasExactSynonym
X-linked Charcot-Marie-Tooth disease type 2
rdf-schema#subClassOf
t365876
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_rare_slim
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000149
relatedICD
http://example.org/icd10/G60.0
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.